Skip to content
Home/Companies/HealthTech/PredictImmune
PR

PredictImmune

HealthTech·UK·Exited 2024·Held 5yr

PredictImmune is a HealthTech company, headquartered in UK.

Entry
2019
Hold
5yr
Exit
2024
Est. EV
–

Who owns PredictImmune?

PredictImmune was owned by Cambridge Innovation Capital through CIC Fund I (2013 vintage) from 2019 to 2024, exited via Liquidation.

Hand-verified · updated 2026-06-21

Cambridge Innovation Capital
Investor
Cambridge Innovation Capital
CIC Fund I · 2013 · VC

Key facts

HQUK
SectorHealthTech
StatusAcquired
Exit Type
Liquidation
Buyer
–
MOIC
–
Exit Year
2024

More from CIC Fund I

Other portfolio companies in the same fund.

Seldon
Exited 2026
AI/MLUK· 2020
Gyroscope Therapeutics
Exited 2021
BiotechUK· 2019
to
Sense Biodetection
Active
MedTechUK· 2019
Audio Analytic
Exited 2022
AI/MLUK· 2017
to
Cytora
Exited 2025
InsurTechUK· 2017
to
Riverlane
Active
Deep TechUK· 2017

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

CIGA Healthcare
Active
Clarendon Fund ManagersUK
Paladin
Active
Ring CapitalFrance
Theraclion
Exited 2014
KaristaFrance
to
Access Infinity
Active
CBPE CapitalUK· 2026
Brightheart
Active
Odyssée VentureFrance· 2026
Dermascan
Active
Ring CapitalFrance· 2026
Data refreshed weekly · Sourced from public filings